DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study

Junwei Chen,Lisha Lai,Junyang Luo,Haofan Wang,Mingan Li,Mingsheng Huang

DOI: https://doi.org/10.1186/s12885-022-10361-5

IF: 4.638

2022-12-02

BMC Cancer

Abstract:Conventional-transarterial chemoembolization (C-TACE) was proven to improve overall survival (OS) in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT), drug-eluting microsphere-TACE (DEM-TACE) was supposed to provide more benefit than C-TACE in this respect.

oncology